LINC02379

Across TCGA pan-cancer cohorts, LINC02379 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated LINC02379 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02379 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02379 expression acts as an unfavorable survival marker.

STAD, OV, and BLCA are the cancer types where LINC02379 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.212	0.740	<.001	63	view →
OV	DFS	Tertile	All	0.258	0.542	.014	54	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
BRCA	OS	Tertile	II,III,IV	0.138	0.566	<.001	36	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
PRAD	DFS	Tertile	All	0.163	0.774	.005	18	view →
SARC	OS	Tertile	All	0.460	0.864	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

LINC02379–STAD (OS)

Open the STAD breakdown →